New combo pill could boost weight loss and fight inflammation
NCT ID NCT07220629
First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 28 times
Summary
This study tests whether adding an experimental drug (NT-0796) to semaglutide (a weight-loss medication), along with diet and exercise, helps people with obesity lose more weight and reduce inflammation. About 82 adults with a BMI of 30 or higher will receive either the combination or a placebo for 6 months. The main goals are to check safety and see if the drug lowers body weight and markers of inflammation like hsCRP.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Investigative Site
Mesa, Arizona, 85225, United States
-
Investigative Site
Hialeah, Florida, 33016, United States
-
Investigative Site
Jacksonville, Florida, 32216, United States
-
Investigative Site
Miami, Florida, 33147, United States
-
Investigative Site
Marrero, Louisiana, 70006, United States
-
Investigative Site
Columbus, Ohio, 43213, United States
-
Investigative Site
Seabrook, Texas, 77586, United States
-
Investigative Site
Salt Lake City, Utah, 84124, United States
-
Investigative Site
Manassas, Virginia, 20110, United States
Conditions
Explore the condition pages connected to this study.